[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
 @RxRegA Jessica Adams
 @RxRegA Jessica AdamsJessica Adams posts on X about approved, what was, has been, $gsk the most. They currently have XXXXX followers and X posts still getting attention that total XX engagements in the last XX hours.
Social category influence stocks XXXX%
Social topic influence approved 12.5%, what was 12.5%, has been 12.5%, $gsk 12.5%, see the 12.5%, should be 12.5%, $gsks 12.5%, fda XXXX%
Top accounts mentioned or mentioned by @jacobplieth @fda
Top assets mentioned GSK plc (GSK)
Top posts by engagements in the last XX hours
"@JacobPlieth Will sponsors start digging up their rejected cancer drugs for any sign of potential life in third line post hoc analyses"
X Link @RxRegA 2025-10-24T11:23Z 5854 followers, XX engagements
"Just add another line making Blenrep 3rd line and slap on a REMS and voila it's FDA approved again. Pic shows the adcomm votes"
X Link @RxRegA 2025-10-24T11:01Z 5854 followers, 1162 engagements
"@JacobPlieth My other question after my first question about what was pre-specified for testing is whether the REMS has been at all tested for ability to mitigate risk. Also what is safety in this population"
X Link @RxRegA 2025-10-24T11:39Z 5853 followers, XXX engagements
"$GSK: Here's the new blenrep (belantamab mafodotin-blmf) label I'm curious to see the approval letter and review docs which should be posted to this FDA database w/in a month"
X Link @RxRegA 2025-10-25T11:07Z 5854 followers, XXX engagements
"FDA has posted the approval letter for $GSK's Blemrep showing details of the REMS and postmarket study requirements"
X Link @RxRegA 2025-10-27T20:08Z 5853 followers, XXX engagements